Aleksandra Stojadinović

Aleksandra Stojadinović

Auto-generated profile, based on publicly available information

Aleksandra Stojadinović

Institute for Child and Youth Health Care of Vojvodina , Novi Sad , Serbia

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Medicinski Pregled
Verified
Journal Article
Open access
PDF file
SKSvetlana Kuzmanovic
Svetlana Kuzmanovic
NRNevenka Roncevic
Nevenka Roncevic
ASAleksandra Stojadinovic
Aleksandra Stojadinovic
Introduction. About 20% of fevers in childhood have no apparent cause. A small, but significant number of these children may have a seroius bacterial infection. Fever without a focus of infection is an acute febrile illness with rectal temperature of 38°C or higher in children younger than 36 months, without localizing signs or symptoms. Practice Guidelines for Medical Care. In this article, practical recommendations for medical care of febrile children 0-36 months of age are given, bearing in mind children's age, clinical presentation (toxic manifestations) and risk for serious bacterial infection (sepsis, meningitis, pneumonia, urinary tract infection...). Toxic appearance is a clinical presentation characterized by lethargy, poor perfusion, marked hypo/hyperventilation and cyanosis. All febrile children under 36 months of age, who are appearing toxic, require hospitalization, evaluation for sepsis and administration of empirical antibiotic therapy. All febrile neonates, however, must be hospitalized: cultures of blood, urine and spinal fluid should be taken and empirical antibiotic therapy administered immediately. Febrile infants, 28 to 90 days of age, need to be evaluated in order to determine whether they are in the low-risk group for serious bacterial infections (Rochester Criteria). Yale Observation Scale is recommended to assess febrile children aged 3-36 months, and the risk of occult bacteriemia. Febrile children, 3-36 months of age who appear well, with temperature of less than 39°C without focus, should be closely followed up without laboratory tests and antibiotics and 2-3 days later reexamined. In febrile children, 3-36 months old, with temperature of 39°C and above, without toxic manifestations, blood culture should be taken and ceftriaxone 50 mg/kg/in a single dose should be given, if leukocyte count is 15000/mm³ or absolute neutrophil count is over 10.000/mm³ .

1 January 2019 in Engrami
Verified
Journal Article
Open access
MGMarijana Grujić
Marijana Grujić
KKKatarina Katić
Katarina Katić
ASAleksandra Stojadinović
Aleksandra Stojadinović

13 June 2025 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
Milena BjelicaMilena Bjelica
Milena Bjelica
ASAleksandra Stojadinović
Aleksandra Stojadinović
MPMarija Knežević Pogančev
Marija Knežević Pogančev
KKKatarina Koprivšek
Katarina Koprivšek
JSJӧrn Oliver Sass
Jӧrn Oliver Sass
RYRaina Yamamoto
Raina Yamamoto
Objectives: 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency (HMGCLD) is a rare autosomal recessive organic aciduria. Most patients present within the first year of life with metabolic decompensation, which can cause neurological damage or death if untreated. Case presentation: A 20-month-old previously healthy boy was admitted to the hospital after a nocturnal seizure. Upon admission, the child was unconscious and laboratory analysis revealed severe hypoglycemia and metabolic acidosis without ketonuria. Hypoglycemia was corrected with a bolus of 10 % glucose followed by continuous glucose-electrolyte infusion. Status epilepticus was treated with midazolam and phenobarbital. Magnetic resonance imaging (MRI) performed on the second hospital day, revealed bilateral and symmetric T2 hyperintense lesions in the cortex, supratentorial white matter, basal ganglia and central pons, along with slight white matter volume reduction. Urinary organic acids indicated HMGCLD. HMG-CoA lyase activity in immortalized lymphocytes was significantly decreased. Sanger sequencing of the HMGCL gene identified a heterozygous sequence variant, c.796T>C, p.(Cys266Arg). MLPA analysis showed a reduced gene dosage for exons 3 and 4 of HMGCL, consistent with a heterozygous deletion. Upon diagnosis, a low-protein diet was recommended, as well as oral l-carnitine therapy with a high-calorie supplement drink at night. Initially, the child had slightly impaired psychomotor development, which normalized by age 3.5. He was without metabolic crises or seizures since diagnosis. Conclusions: In any child presenting with hypoketotic hypoglycemia and metabolic acidosis of unknown etiology, HMGCLD should be considered. Given the rarity of HMGCLD and its sporadic cases across Europe, management should involve a well-experienced multidisciplinary team.